Ethical, Legal and Social Issues arising out of Advancements...
Transcript of Ethical, Legal and Social Issues arising out of Advancements...
Ethics: separate right from wrong as a principle of human duty When applied to systematic studies in biology : Bioethics
Why infectious diseases warrant more of bioethics’ attention?
Infectious means contagious
Contagious means isolation of patient from the rest
Isolation means discrimination
Discrimination means seclusion, loneliness, embarrassment, humiliation, loss of physical and mental health
No isolation means threat to rest of the society
BORDERLINE ZONE BETWEEN INFECTIOUS DISEASES RELATED RESEARCH AND HUMAN RIGHTS
Moral issues in doing research involving infectious diseases
• Primary Goal : generation of useful knowledge about human health and disease, its likely spread and extent of damage possible
• The Human Subjects:o Are means to gather information and knowledge about
understanding the disease o Immediate health benefit to participants is not the purpose
of such studies
…therefore may be at risk of exploitation
Ethics in clinical research
– Minimize exploitation– Protect rights– Maintain dignity – Respect confidentiality – Ensure welfare
….while the subjects contribute to the generation of knowledge
Research in infectious diseases• Starts with field observations involving human
subjects• Mimic similar situation in a laboratory• In vitro studies, identification of targets• Check polymorphism of the target in population• Make a intervention molecule• Studies involving cell culture and animal model• Ends with human clinical trials
Some successful studies we can’t call ethical
– Jenners’ experiment with a young boy of 8 years using Cow Pox (1796)
– Tuskegee Syphilis Study (1932-72)
The Tuskegee Syphilis Experiment: A clear example of ethically unacceptable research by present standards
Source:http://en.wikipedia.org/wiki/File:Syphilis-posster
• What do we do with the results of immoral research?– “the Tuskegee study was and remains
a key source of information about …syphilis.” (Caplan, 419)
Codes of Research Ethics
• Nuremberg Code (1947)– informed consent, societal value, unacceptable levels
of risk• Declaration of Helsinki (orig. 1964)
– added written protocol, independent review• Belmont Report (1979)
– added justice, fair subject selection• Council for International Organizations of
Medical Sciences (CIOMS) International Ethical Guidelines for Biomedical Research (1993, Updated 2002)
Ethical framework while working with human subjects: 9 principles• Valuable scientific question• Valid scientific methodology• Favorable risk-benefit evaluation• Fair subject selection• Informed consent• Confidentiality• Respect for enrolled subjects • Scientific integrity• Independent reviewAdapted from: Emanuel E, Wendler D, Grady C. What makes clinical research ethical? Journal of the
American Medical Association 2000; 283(20):2701-11
Valuable scientific questionIs the research outcome a burden
or benefit?
Research as ‘burden’
Subjects need protection
Research as ‘benefit’
Subjects need access
Benefit-Risk-Balance• Minimize risks to subjects• Maximize benefits to individual subjects and to society• Enough preliminary evidence before commencement of
clinical trials• Start with case control studies
RISKS
Benefit to society
?
Cease . . . investigation if:the risks are found to outweigh the potential benefits, or there is conclusive proof of positive and beneficial results (Helsinki Declaration)
Fair Subject SelectionSelection of subjects related to the purpose of the study, not because they are readily available, vulnerable, or otherwise easily exploited, or are favoured.
Do not exclude subjects without a good reason of science, vulnerability, or susceptibility to risk or burden.
Choice of control population for proper conclusions from the study
Vulnerability• There is an order of preference in selecting subjects, for
instance, adults before children (Belmont Report)• Exclude vulnerable subjects unless their participation is
needed for scientific reasons (CIOMS)
Vulnerable group
Research group
A human subject should be at liberty to bring the experiment to an end . . .
Psychological harm Social stigmaCultural effects Economic repercussions
… or even without reasons
Informed Consent:Respect for Persons
Voluntary agreement to participate: After weighing the objectives, risks, benefits, and alternatives of
the research.
•Nuremberg Code•CIOMS guidelines•The Belmont Report
Extra protections for those with limited capacity to consent
What happens when consent can’t be taken
“When it is not possible to request informed consent from every individual to be studied, the agreement of a representative of a community or group should be sought, but the representative should be chosen according to the nature, traditions and political philosophy of the community or group.”
CIOMS
Epidemiological studies may involve genetic information
• Not only information about an individual, but also about those to whom the individual is related
• If genetic testing is involved for any study a non-directive, culturally adapted genetic counselling should be made available
• Clear directions for sharing such informationUNESCO Int’l Declaration, Art. 11
–Is there a duty to warn family members of being at risk?
Independent Review: Institutional Review Board
Ensure:Risks are minimizedRisks are justified by expected benefits and knowledge to be gainedJustifiable subject selection Fair treatment to subjectsInformed consent is adequate
Suggest:Possible methodology before
commencement of the study
Biosafety is also an integral part of Bioethics
• Proper waste disposal– Proper decontamination– Proper segregation– Proper packing
Reporting Ethics in Infectious Diseases
- Is it research or audit or clinical practice?- Disclose if similar studies have been performed
earlier- Disclose if it differs from earlier reports- Should not alter or ignore some data to make the
results look statistically better- Patients’ identity and other relevant medical
details should remain confidential– Important to report exceptional cases
REGISTRATION A prerequisite for all Clinical Trials
•Trials must register at or before the onset of patient enrollment.
•Selective reporting distorts clinical decision-making.
•Financial benefits may hide important trials
•Right to information of trials
•Undue importance to some clinical trials for benefit of selected pharmaceutical companies
•Biased publications: Positive trials are more likely to be submitted for publication and also published quickly than negative trials
JAMA 2002;287:2825-2828. Stern and Simes BMJ 1997;315:640-645